There is evidence of short-term efficacy (moderate for pain and small for function) of opioids for treatment of chronic low back pain (CLBP) compared with placebo; however, the effectiveness and safety of long-term opioid therapy for treatment of CLBP remains unproven, according to a review published in the April 1 issue of Spine.
Implementation of a brief psychosocial education program achieves only modest savings in low back pain-related health care costs, according to a study published in the April 1 issue of The Spine Journal.
Low back pain, including that arising from ergonomic exposures at work, is associated with considerable global disability and burden, according to two studies published online March 24 in the Annals of the Rheumatic Diseases.
According to a recent systematic review, the prescient and short-term use of NSAIDs and opioids with pharmacological sensitivity to an individual’s comorbidities may result in pain relief, improved functioning, and reduced vocational and avocational absenteeism.
In light of the fact that many physicians continue to rely on observational analysis and patient self-reporting to monitor opioid addiction or misuse, results from a scientific poster reinforced the benefits of routine urine drug testing in improving compliance with prescribed opioid medications and ultimately enhancing pain care.
For patients treated for low back pain, catastrophizing may predict the degree of pain and disability, according to a review published in the Feb. 1 issue of Spine.